Article Details

Anokion Announces Initiation of Multiple-Ascending Dose Portion of its Phase 1 Clinical Trial with ...

Retrieved on: 2021-03-16 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Anokion Announces Initiation of Multiple-Ascending Dose Portion of its Phase 1 Clinical Trial with .... View article details on hiswai:

Excerpt

By restoring natural immune tolerance, we believe KAN-101 could significantly ... to re-educate the immune system by targeting the body's own natural immune ... Anokion SA is a Swiss biotechnology company that aims to make a ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo